Table 1. Correlation between lncRNA-LET expression and clinicopathologic characteristics in NSCLC patients.
| Characteristics | n | lncRNA-LET expression | χ2-Value | P-Value | |
|---|---|---|---|---|---|
| Low | High | ||||
| Gender | |||||
| Male | 46 | 22 | 24 | 0.026 | 0.871 |
| Female | 20 | 10 | 10 | ||
| Age | |||||
| <55 | 18 | 8 | 10 | 2.802 | 0.246 |
| 55-64 | 35 | 15 | 20 | ||
| ≥65 | 13 | 9 | 4 | ||
| T status | |||||
| T1-2 | 50 | 20 | 30 | 9.504 | 0.009 |
| T3-4 | 16 | 12 | 4 | ||
| N status | |||||
| N0 | 32 | 14 | 18 | 6.445 | 0.040 |
| N1/2 | 34 | 18 | 16 | ||
| Clinical stage | |||||
| I–II | 32 | 11 | 21 | 4.951 | 0.026 |
| III–IV | 34 | 21 | 13 | ||
| Histological grade | |||||
| Well and moderately | 20 | 6 | 14 | 3.926 | 0.048 |
| Poorly and others | 46 | 26 | 20 | ||
| Lymphatic metastasis | |||||
| Negative | 21 | 3 | 18 | 14.422 | <0.001 |
| Positive | 45 | 29 | 16 | ||